Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

44 та иш

Иш: Evaluation of Antifibrotic Activity of a Combination of a New Phytocomposition and Proanthocyanidins in Rats.

  1. Proteins from the Aerial Part of Delphinium leptocarpum and Their Biological Activity

    Sh. Kh. Rakhimova, U. Kh. Kurbanov, L. G. Mezhlumyan +4

    МақолаPlant-based Medicinal ResearchChemistry of Natural Compounds20234 иқтибос
    ABI

  2. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

    Ali A. Mokdad, Alan D López, Saied Shahraz +5

    Мақола20144 иқтибос
    ABI

  3. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety

    Martins Ekor

    Шарҳ мақола20144 иқтибос
    ABI

  4. CHEMICAL COMPOSITION AND BIOLOGICAL ACTIVITY OF METABOLITES OF THE GENUS ALHAGI

    S. Z. Nishanbaev, Il'dar Dzhamil'yevich Sham’yanov, Khayrulla Bobakulov +1

    Мақола20194 иқтибос
    ABI

  5. Neutral substances from Alhagi pseudalhagi

    Н. М. Маматкулова, D. F. Alimova, S. Z. Nishanbaev +2

    МақолаGarlic and Onion StudiesChemistry of Natural Compounds20123 иқтибос
    ABI

  6. Hepatoprotective Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, and Lycopene in Experimental Chronic Hepatitis Compared to Phosphogliv

    В. Н. Сыров, S. D. Gusakova, З. А. Хушбактова +3

    МақолаPharmacological Effects of Natural CompoundsPharmaceutical Chemistry Journal20233 иқтибос
    ABI

  7. Antifibrotic Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, Lycopene and Proanthacyanidin in Experimental Severe Chronic Hepatitis Compared with Phosphogliv

    A. N. Aripov, L. L. Akhunzhanova, A. U. Nabiev +2

    МақолаPharmacological Effects of Natural CompoundsBiomedical & Pharmacology Journal20233 иқтибос
    ABI

  8. Global epidemiology of cirrhosis — aetiology, trends and predictions

    Daniel Q. Huang, Norah A. Terrault, Frank Tacke +4

    Шарҳ мақола20233 иқтибос
    ABI

  9. Liver fibrosis and repair: immune regulation of wound healing in a solid organ

    Antonella Pellicoro, Prakash Ramachandran, John P. Iredale +1

    Шарҳ мақола20143 иқтибос
    ABI

  10. AASLD guidelines for the treatment of hepatocellular carcinoma

    Julie K. Heimbach, Laura Kulik, Richard S. Finn +6

    Мақола20172 иқтибос
    ABI

  11. Liver cirrhosis

    Pere Ginès, Aleksander Krag, Juan G Abraldes +3

    Мақола20212 иқтибос
    ABI

  12. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

    Gennaro D’Amico, Guadalupe García–Tsao, Luigi Pagliaro

    Шарҳ мақола20052 иқтибос
    ABI

  13. Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis.

    Jürg Reichen, Bernhard Egger, N. Ohara +3

    Мақола19882 иқтибос
    ABI

  14. CYTOKINE PROFILE OF RAT BLOOD IN EXPERIMENTAL PERIODONTIS AND EFFECT OF IMMUNE MODULATORS

    Evgeniy Mokrenko, A.Y. Vyazmin, Петр Д. Шабанов +3

    Мақола20202 иқтибос
    ABI

  15. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Мақола20222 иқтибос
    ABI

  16. rgho: Access WHO Global Health Observatory Data from R

    Kevin Zarca, Antoine Filipović-Pierucci

    Бошқа20162 иқтибос
    ABI

  17. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  18. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI